Richard /ca/ Murray

Richard /ca/ Murray has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Jounce Therapeutics, Inc. and PDL Biopharma, Inc. Over a trading history stretching from 3 March 2006 to 3 May 2023, the count stands at 43 filings.

The open-market record consists of 19 sales worth €2.9M, with no purchase. Besides market trades, the filings include 11 share grants and 12 option exercises. In 2023 alone, the filings show no purchases and 3 sales.

Most recently, on 4 May 2023, the filings show a transaction in Jounce Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.